Proactiveinvestors Australia Achillion Pharmaceuticals, Inc. https://www.proactiveinvestors.com.au Proactiveinvestors Australia Achillion Pharmaceuticals, Inc. RSS feed en Fri, 28 Feb 2020 23:17:31 +1100 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Achillion Pharmaceuticals stock climbs on promising Phase 2 data for its blood-disorder treatment https://www.proactiveinvestors.com.au/companies/news/220526/achillion-pharmaceuticals-stock-climbs-on-promising-phase-2-data-for-its-blood-disorder-treatment-220526.html Fri, 17 May 2019 13:45:00 +1000 https://www.proactiveinvestors.com.au/companies/news/220526/achillion-pharmaceuticals-stock-climbs-on-promising-phase-2-data-for-its-blood-disorder-treatment-220526.html Achillion crumbles as FDA keeps hold on Hepatitis C drug https://www.proactiveinvestors.com.au/companies/news/97650/achillion-crumbles-as-fda-keeps-hold-on-hepatitis-c-drug-48516.html Mon, 30 Sep 2013 13:58:00 +1000 https://www.proactiveinvestors.com.au/companies/news/97650/achillion-crumbles-as-fda-keeps-hold-on-hepatitis-c-drug-48516.html Achillion reports preliminary results from early stage Hep C trial https://www.proactiveinvestors.com.au/companies/news/81941/achillion-reports-preliminary-results-from-early-stage-hep-c-trial-22046.html Mon, 05 Dec 2011 17:38:00 +1100 https://www.proactiveinvestors.com.au/companies/news/81941/achillion-reports-preliminary-results-from-early-stage-hep-c-trial-22046.html Achillion achieves top-line results from phase 2 trial for hep C drug https://www.proactiveinvestors.com.au/companies/news/76912/achillion-achieves-top-line-results-from-phase-2-trial-for-hep-c-drug-13432.html Wed, 30 Mar 2011 14:06:00 +1100 https://www.proactiveinvestors.com.au/companies/news/76912/achillion-achieves-top-line-results-from-phase-2-trial-for-hep-c-drug-13432.html Achillion Pharmaceuticals receives key US patent for Hep C drug https://www.proactiveinvestors.com.au/companies/news/76690/achillion-pharmaceuticals-receives-key-us-patent-for-hep-c-drug-12982.html Wed, 16 Mar 2011 14:07:00 +1100 https://www.proactiveinvestors.com.au/companies/news/76690/achillion-pharmaceuticals-receives-key-us-patent-for-hep-c-drug-12982.html